Sign in

CIK 0000886744 · Large accelerated filer

Ticker
GERN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
752287752
Phone
6504737700
Business address
919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
Former names
GERON CORPORATION
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Director acquired 5,540 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Director bought 13,300 shares at $1.18 ($15,667)
  12. 4 Grant or award Director acquired 4,913 shares (grant or award)
  13. 4/A Grant or award Director acquired 2,206 shares (grant or award)
  14. 4/A Grant or award Director acquired 1,767 shares (grant or award)
  15. 4/A Grant or award Director acquired 4,378 shares (grant or award)
  16. 4 Open-market buy EVP, Chief Legal Officer bought 15,000 shares at $1.61 ($24,150)
  17. 4 Open-market buy Chairman, President and CEO bought 12,500 shares at $1.77 ($22,063)
  18. 4 Open-market buy EVP, Chief Commercial Officer bought 100,000 shares at $1.60 ($160,000)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 35 · 690 filings